LAMISA RAYSIDE: Open Payments
NPI 1205151677 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 22 payments from 9 companies in 2025. Trend: 2023 $1,118 · 2024 $1,130 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $371 |
| ABBVIE INC. | 9 | $267 |
| Novo Nordisk Inc | 1 | $109 |
| Globus Medical, Inc. | 1 | $28 |
| Nalu Medical, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Curonix LLC | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Electronic Waveform Lab, Inc. | 1 | $9 |
Products named: Intracept, QULIPTA, BOTOX, WaveWriter Alpha Prime 16, Senza, Nalu Neurostimulation System, JOURNAVX, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A.
Industry payments across FL — which companies pay providers there.
